![Wayne Paterson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Wayne Paterson
Chief Executive Officer at
Anteris Technologies Ltd.
Net worth: 2 M $ as of 2026-08-30
Profile
Mr. Wayne G.
Paterson is a Chairman at V2vmedtech, Inc., a Vice Chairman & Chief Executive Officer at Anteris Technologies Pty Ltd., a Vice Chairman, Chief Executive Officer & Secretary at Anteris Technologies Global Corp., a Chairman at Constellation Therapeutics Ltd. and a Chief Executive Officer at Procom RX.
He is on the Board of Directors at Anteris Technologies Pty Ltd. and Anteris Technologies Global Corp.
Mr. Paterson was previously employed as a Non-Executive Director by CEPHEID, a President-Emerging Markets, President-Japan Region by Merck KGaA, a Head-Commercial Operations by Roche (China) Investment Co., Ltd., and a Head-South Korea Operation Phatmaceuticals by Roche Pharmaceuticals, Inc. He also served on the board at Admedus Biomanufacturing Pty Ltd. and Merck Serono SA. He received his undergraduate degree from Queensland University of Technology and an MBA from the University of Southern Queensland.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
0.21% | 2025-12-15 | 203,061 ( 0.21% ) | 2 M $ | 2026-08-30 |
Wayne Paterson active positions
| Companies | Position | Start |
|---|---|---|
Anteris Technologies Ltd.
 Anteris Technologies Ltd. Medical SpecialtiesHealth Technology Engages in designing, developing and commercializing of medical devices to restore healthy heart function | Chief Executive Officer | 2025-02-28 |
Procom RX | Chief Executive Officer | - |
Constellation Therapeutics Ltd.
 Constellation Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as medical research institute | Chairman | - |
V2vmedtech, Inc.
 V2vmedtech, Inc. Miscellaneous Commercial ServicesCommercial Services Owns intellectual property rights | Chairman | 2023-03-31 |
Former positions of Wayne Paterson
| Companies | Position | End |
|---|---|---|
| CEPHEID | Director/Board Member | 2016-10-31 |
| MERCK KGAA | Corporate Officer/Principal | 2012-12-31 |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Corporate Officer/Principal | 2004-12-31 |
Roche (China) Co. Ltd.
 Roche (China) Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in pharmaceutical research and development | Corporate Officer/Principal | 2004-12-31 |
Admedus Biomanufacturing Pty Ltd.
 Admedus Biomanufacturing Pty Ltd. BiotechnologyHealth Technology Manufactures bio-implant products | Director/Board Member | - |
Training of Wayne Paterson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
60
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
CEPHEID
 CEPHEID Medical SpecialtiesHealth Technology Develops, manufactures and markets molecular diagnostic systems | Health Technology |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
Queensland University of Technology
 Queensland University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Southern Queensland
 University of Southern Queensland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Serono SA
 Merck Serono SA Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for reproductive and metabolism | Health Technology |
Roche (China) Co. Ltd.
Roche (China) Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in pharmaceutical research and development | Commercial Services |
Anteris Technologies Ltd.
Anteris Technologies Ltd. Medical SpecialtiesHealth Technology Engages in designing, developing and commercializing of medical devices to restore healthy heart function | Health Technology |
Admedus Biomanufacturing Pty Ltd.
Admedus Biomanufacturing Pty Ltd. BiotechnologyHealth Technology Manufactures bio-implant products | Health Technology |
Procom RX | |
Constellation Therapeutics Ltd.
Constellation Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as medical research institute | Commercial Services |
V2vmedtech, Inc.
V2vmedtech, Inc. Miscellaneous Commercial ServicesCommercial Services Owns intellectual property rights | Commercial Services |
- Stock Market
- Insiders
- Wayne Paterson
